Outcomes of patients with primary central nervous system lymphoma following CD19-targeted chimeric antigen receptor T-cell therapy

Santiago Mercadal; Kwang Woo Ahn; Mariam Allbee-Johnson; Siddhartha Ganguly; Praveen Ramakrishnan Geethakumari; Sanghee Hong; Adriana Malone; Hemant Murthy; Attaphol Pawarode; R. Alejandro Sica; Melhem Solh; Celalettin Ustun; Mazyar Shadman; Craig S. Sauter; Mehdi Hamadani; Alex F. Herrera; Catherine J. Lee

doi:10.3324/haematol.2024.285613

Outcomes of patients with primary central nervous system lymphoma following CD19-targeted chimeric antigen receptor T-cell therapy

Santiago Mercadal, Kwang Woo Ahn, Mariam Allbee-Johnson, Siddhartha Ganguly, Praveen Ramakrishnan Geethakumari, Sanghee Hong, Adriana Malone, Hemant Murthy, Attaphol Pawarode, R. Alejandro Sica, Melhem Solh, Celalettin Ustun, Mazyar Shadman, Craig S. Sauter, Mehdi Hamadani, Alex F. Herrera, Catherine J. Lee

Research output: Contribution to journal › Letter › peer-review

1 Scopus citations

Original language	English
Pages (from-to)	218-221
Number of pages	4
Journal	Haematologica
Volume	110
Issue number	1
DOIs	https://doi.org/10.3324/haematol.2024.285613
State	Published - Jan 2025

Access to Document

10.3324/haematol.2024.285613

Cite this

Mercadal, S., Ahn, K. W., Allbee-Johnson, M., Ganguly, S., Geethakumari, P. R., Hong, S., Malone, A., Murthy, H., Pawarode, A., Sica, R. A., Solh, M., Ustun, C., Shadman, M., Sauter, C. S., Hamadani, M., Herrera, A. F., & Lee, C. J. (2025). Outcomes of patients with primary central nervous system lymphoma following CD19-targeted chimeric antigen receptor T-cell therapy. Haematologica, 110(1), 218-221. https://doi.org/10.3324/haematol.2024.285613

@article{e199dc0b0ee94212837f318ea5e06f8e,

title = "Outcomes of patients with primary central nervous system lymphoma following CD19-targeted chimeric antigen receptor T-cell therapy",

author = "Santiago Mercadal and Ahn, {Kwang Woo} and Mariam Allbee-Johnson and Siddhartha Ganguly and Geethakumari, {Praveen Ramakrishnan} and Sanghee Hong and Adriana Malone and Hemant Murthy and Attaphol Pawarode and Sica, {R. Alejandro} and Melhem Solh and Celalettin Ustun and Mazyar Shadman and Sauter, {Craig S.} and Mehdi Hamadani and Herrera, {Alex F.} and Lee, {Catherine J.}",

year = "2025",

month = jan,

doi = "10.3324/haematol.2024.285613",

language = "English",

volume = "110",

pages = "218--221",

journal = "Haematologica",

issn = "0390-6078",

publisher = "Ferrata Storti Foundation",

number = "1",

}

Mercadal, S, Ahn, KW, Allbee-Johnson, M, Ganguly, S, Geethakumari, PR, Hong, S, Malone, A, Murthy, H, Pawarode, A, Sica, RA, Solh, M, Ustun, C, Shadman, M, Sauter, CS, Hamadani, M, Herrera, AF & Lee, CJ 2025, 'Outcomes of patients with primary central nervous system lymphoma following CD19-targeted chimeric antigen receptor T-cell therapy', Haematologica, vol. 110, no. 1, pp. 218-221. https://doi.org/10.3324/haematol.2024.285613

TY - JOUR

T1 - Outcomes of patients with primary central nervous system lymphoma following CD19-targeted chimeric antigen receptor T-cell therapy

AU - Mercadal, Santiago

AU - Ahn, Kwang Woo

AU - Allbee-Johnson, Mariam

AU - Ganguly, Siddhartha

AU - Geethakumari, Praveen Ramakrishnan

AU - Hong, Sanghee

AU - Malone, Adriana

AU - Murthy, Hemant

AU - Pawarode, Attaphol

AU - Sica, R. Alejandro

AU - Solh, Melhem

AU - Ustun, Celalettin

AU - Shadman, Mazyar

AU - Sauter, Craig S.

AU - Hamadani, Mehdi

AU - Herrera, Alex F.

AU - Lee, Catherine J.

PY - 2025/1

Y1 - 2025/1

UR - http://www.scopus.com/inward/record.url?scp=85214317988&partnerID=8YFLogxK

U2 - 10.3324/haematol.2024.285613

DO - 10.3324/haematol.2024.285613

M3 - Letter

C2 - 39234871

AN - SCOPUS:85214317988

SN - 0390-6078

VL - 110

SP - 218

EP - 221

JO - Haematologica

JF - Haematologica

IS - 1

ER -